help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 24, 2005
Molecular Endocrinology, doi:10.1210/me.2004-0111
Molecular Endocrinology Vol. 0, No. 2005 200401111-
doi:10.1210/me.2004-0111
Copyright © 2005 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
19/7/1904    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J. C.
Right arrow Articles by Elsholtz, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J. C.
Right arrow Articles by Elsholtz, H. P.

Submitted on March 16, 2004
Accepted on February 18, 2005

Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene

Jeffrey C. Liu, Ross E. Baker, Winsion Chow, Christopher K. Sun, and Harry P. Elsholtz*

Department of Laboratory Medicine and Pathobiology, Banting and Best Diabetes Centre, University of Toronto and the Toronto General Hospital Research Institute

* To whom correspondence should be addressed. E-mail: h.elsholtz{at}utoronto.ca.

Transcription of the prolactin gene is dynamically controlled by positive and negative hormone signals that target the regulatory promoter region. Based on the inducibility of prolactin gene expression by inhibitors of histone deacetylases, we examined the role of histone acetylation at the genomic prolactin promoter as a late step in transcriptional regulation. Chromatin immunoprecipitation analysis of GH4 cells revealed elevated levels of acetylated histones in the promoter and enhancer regions of the gene, compared with downstream intron sequences. Estradiol 17-beta stimulated histone H4 acetylation in the promoter region by 2 to 3-fold within 30 min. Dopamine inhibited histone H4 acetylation by 2-fold in 30 min, an effect mimicked by the MAPK kinase inhibitor U0126. In contrast, the synthetic glucocorticoid dexamethasone, which inhibits prolactin transcription, failed to alter histone acetylation over the same time frame. Association of transcription activator Pit-1 with the prolactin promoter was unchanged by hormone treatment. However, in response to dopamine, histone deacetylase HDAC2 and corepressor mSin3A were rapidly recruited to the prolactin promoter and association sustained above basal levels over a one hour period. Consistent with this corepressor function, depletion of endogenous mSin3A by siRNA was sufficient to enhance prolactin gene expression by 70%, comparable to the induction by the HDAC inhibitor, TSA. These studies demonstrate that dopamine D2 receptor activation and inhibition of ERK1/2 signaling lead to rapid deacetylation of histones at the genomic prolactin promoter. Recruitment of specific HDAC/ corepressor complexes may be an important mechanism for repression of target gene transcription by Gi/o-coupled receptors.


Key words: dopamine D2 receptors • prolactin gene transcription • HDAC/mSin3A recruitment • histone acetylation • chromatin analysis




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. D. Adamson, S. Friedrichsen, S. Semprini, C. V. Harper, J. J. Mullins, M. R. H. White, and J. R. E. Davis
Human Prolactin Gene Promoter Regulation by Estrogen: Convergence with Tumor Necrosis Factor-{alpha} Signaling
Endocrinology, February 1, 2008; 149(2): 687 - 694.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
X. Zhu, A. S. Gleiberman, and M. G. Rosenfeld
Molecular Physiology of Pituitary Development: Signaling and Transcriptional Networks
Physiol Rev, July 1, 2007; 87(3): 933 - 963.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society